Research Use Only
NAD+
CAS #53-84-9
$81.00
NAD+ (Nicotinamide Adenine Dinucleotide)
- CAS #
- 53-84-9
- Suggested Association
- DNA repair, gene expression regulation, cellular signaling pathways
- Indicated Involvement
- Metabolic reactions, energy metabolism, ATP synthesis, mitochondrial function
Not currently approved for therapeutic use by the FDA
References
- National Institutes of Health (NIH). NAD+ Research and Applications.
- FDA. Drug Approvals and Databases.
- Imai, S.-I., & Yamamoto, M. (2013). NAD+ and NADH in Regulation of Cellular Functions.
- Jiang, H.Y., et al. (2017). NAD+ as a Therapeutic Target in Metabolic Disorders.